Posted by Michael Wonder on 31 Jan 2019
Schedule of Pharmaceutical Benefits - 1 February 2019 update
1 February 2019 - The February 2019 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The February issue of the Schedule includes a number of new/revised listings:
- Guselkumab (Tremfya) - new medicine
- Iron isomaltoside (Monofer) - new formulation
- Osimertinib mesyate (Tagrisso) - new medicine
- Tildrakizumab (Ilumya) - new medicine
